1 | Drevinskaitė, Mingailė; Kačėnienė, Augustė; Linkevičiūtė-Ulinskienė, Donata; Smailytė, Giedrė. The impact of metformin on survival in diabetic endometrial cancer patients: a retrospective population-based analysis // Journal of diabetes and metabolic disorders. Cham : Springer Science and Business Media Deutschland GmbH. eISSN 2251-6581. 2024, vol. 23, iss. 1, p. 841-847. DOI: 10.1007/s40200-023-01358-3. [DB: Emerging Sources Citation Index (Web of Science), Scopus] |
2 | Drevinskaitė, Mingailė; Kačėnienė, Augustė; Patašius, Aušvydas; Stukas, Rimantas; Germanavičius, Arūnas; Mišeikytė, Eglė; Urbonas, Vincas; Smailytė, Giedrė. Cancer mortality and morbidity among patients with schizophrenia: A hospital-based cohort study, 1992-2020 // Acta Psychiatrica Scandinavica : John Wiley and Sons Inc. ISSN 0001-690X. eISSN 1600-0447. 2024, vol. 149, iss. 3, p. 234-243. DOI: 10.1111/acps.13651. [DB: Scopus, MEDLINE, Science Citation Index Expanded (Web of Science)] [IF: 5.000; AIF: 3.600; Q1 (2024 InCities JCR SCIE)] |
3 | Jonušas, Justinas; Patašius, Aušvydas; Drevinskaitė, Mingailė; Ladukas, Adomas; Linkevičiūtė-Ulinskienė, Donata; Zabulienė, Lina; Smailytė, Giedrė. Metformin in chemoprevention of lung cancer: a retrospective population-based cohort study in Lithuania // Medicina (Lithuania). Basel : MDPI. ISSN 1010-660X. eISSN 1648-9144. 2024, vol. 60, iss. 8, art. no. 1275, p. [1-10]. DOI: 10.3390/medicina60081275. [DB: Science Citation Index Expanded (Web of Science), Scopus] [IF: 2.400; AIF: 3.000; Q1 (2024 InCities JCR SCIE)] |
4 | Jonušas, Justinas; Drevinskaitė, Mingailė; Linkevičiūtė-Ulinskienė, Donata; Ladukas, Adomas; Patašius, Aušvydas; Zabulienė, Lina; Smailytė, Giedrė. The risk of cancer among insulin glargine users in Lithuania: A retrospective population-based study // Open medicine : Walter de Gruyter GmbH. ISSN 2391-5463. eISSN 2391-5463. 2024, vol. 19, iss. 1, art. no. 20241017, p. [1-7]. DOI: 10.1515/med-2024-1017. [DB: Scopus, MEDLINE, Science Citation Index Expanded (Web of Science)] [IF: 1.600; AIF: 3.000; Q2 (2024 InCities JCR SCIE)] |